Found: 7
Select item for more details and to access through your institution.
Meta‐Analyses on the Effects of Disease‐Modifying Antirheumatic Drugs on the Most Relevant Patient‐Reported Outcome Domains in Rheumatoid Arthritis.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 8, p. 1659, doi. 10.1002/acr.24965
- By:
- Publication type:
- Article
Diagnostic Performance and Clinical Utility of Referral Rules to Identify Primary Care Patients at Risk of an Inflammatory Rheumatic Disease.
- Published in:
- Arthritis Care & Research, 2022, v. 74, n. 12, p. 2100, doi. 10.1002/acr.24789
- By:
- Publication type:
- Article
Correction to: The impact of different (rheumatoid) arthritis phenotypes on patients' lives.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Correction to: Comparing cost-utility of DMARDs in autoantibody-negative rheumatoid arthritis patients.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
likelihood of attaining and maintaining DMARD-free remission for various (rheumatoid) arthritis phenotypes.
- Published in:
- Rheumatology, 2022, v. 61, n. 6, p. 2275, doi. 10.1093/rheumatology/keab631
- By:
- Publication type:
- Article
Comparing cost-utility of DMARDs in autoantibody-negative rheumatoid arthritis patients.
- Published in:
- Rheumatology, 2021, v. 60, n. 12, p. 5765, doi. 10.1093/rheumatology/keab251
- By:
- Publication type:
- Article
The impact of different (rheumatoid) arthritis phenotypes on patients' lives.
- Published in:
- Rheumatology, 2021, v. 60, n. 8, p. 3716, doi. 10.1093/rheumatology/keaa845
- By:
- Publication type:
- Article